Literature DB >> 28585487

Improvement of nonalcoholic fatty liver disease in morbidly obese patients after sleeve gastrectomy: association of ultrasonographic findings with lipid profile and liver enzymes.

Jaime Ruiz-Tovar1, Maria Engracia Alsina2, Maria Remedios Alpera3.   

Abstract

BACKGROUND: After bariatric surgery an improvement or even complete resolution of nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients is achieved, but little is known about the effect of laparoscopic sleeve gastrectomy (LSG). PATIENTS AND METHODS: A prospective observational study of patients undergoing LSG was performed. An abdominal ultrasonography and blood sample extraction (investigating liver enzymes and lipid profile) were performed preoperatively and 12 months after surgery.
RESULTS: Fifty patients were included in the study. Preoperatively, 84% of the patients presented liver steatosis. A significant reduction of steatosis could be observed 12 months after surgery (p < .001). Preoperative degree of steatosis showed a direct correlation with AST (p = .008) and ALT (p = .007) and an inverse correlation with HDL-cholesterol (p = .019). The reduction of liver steatosis showed an inverse correlation with the increase of HDL-cholesterol between pre- and postoperative determinations (p = .008).
CONCLUSIONS: Liver steatosis, as measured by ultrasonography, improves after sleeve gastrectomy, achieving a complete resolution in 90% of the cases. Preoperative steatosis correlates directly with AST and ALT levels and inversely with HDL-cholesterol. The postoperative increase of HDL-cholesterol shows an inverse correlation with liver steatosis improvement, suggesting that it could be a good marker for monitoring the postoperative liver status.

Entities:  

Keywords:  Liver steatosis; liver enzymes; nonalcoholic fatty liver disease; ultrasonography

Mesh:

Substances:

Year:  2017        PMID: 28585487     DOI: 10.1080/00015458.2017.1334858

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  6 in total

1.  Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.

Authors:  Deepa V Cherla; Noe A Rodriguez; Roman Vangoitsenhoven; Tavankit Singh; Neal Mehta; Arthur J McCullough; Stacy A Brethauer; Philip R Schauer; Ali Aminian
Journal:  Surg Endosc       Date:  2019-07-29       Impact factor: 4.584

Review 2.  Current Controversies in Metabolic Surgery for Nonalcoholic Fatty Liver Disease.

Authors:  Iraklis Perysinakis; Harilaos C Pappis; Elias Margaris
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

Review 3.  Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis.

Authors:  Miller Barreto de Brito E Silva; Francisco Tustumi; Antonio Afonso de Miranda Neto; Anna Carolina Batista Dantas; Marco Aurélio Santo; Ivan Cecconello
Journal:  Obes Surg       Date:  2021-04-13       Impact factor: 4.129

Review 4.  NAFLD as a continuum: from obesity to metabolic syndrome and diabetes.

Authors:  Amélio F Godoy-Matos; Wellington S Silva Júnior; Cynthia M Valerio
Journal:  Diabetol Metab Syndr       Date:  2020-07-14       Impact factor: 3.320

5.  Sustainability of diet-based moderate calorie restriction among obese patients with metabolic-associated fatty liver disease.

Authors:  Hakan Guveli; Tugce Ozlu; Busra Ersoy Tasar; Emre Batuhan Kenger; Eda Kaya
Journal:  Hepatol Forum       Date:  2021-09-15

Review 6.  The advantages and disadvantages of sleeve gastrectomy; clinical laboratory to bedside review.

Authors:  Milad Kheirvari; Nikta Dadkhah Nikroo; Habib Jaafarinejad; Marziye Farsimadan; Sahar Eshghjoo; Sara Hosseini; Taha Anbara
Journal:  Heliyon       Date:  2020-02-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.